Revision as of 18:23, 20 July 2018

Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [1]

Overview

	Hematuria Microchapters
Home
Patient Information
Overview
Definition
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hematuria from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hematuria differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hematuria differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hematuria differential diagnosis
CDC on Hematuria differential diagnosis
Hematuria differential diagnosis in the news
Blogs on Hematuria differential diagnosis
Directions to Hospitals Treating Hematuria
Risk calculators and risk factors for Hematuria differential diagnosis

Gross hematuria(GH) must be distinguished from pigmenturia, which may be due to endogenous sources (e.g., bilirubin, myoglobin,and porphyrins), foods ingested (e.g., beets and rhubarb), drugs (e.g., phenazopyridine), and simple dehydration. This distinction can be made easily by urinalysis with microscopy. Notably, myoglobinuria and other factors can cause false-positive chemical tests for hemoglobin, so urine microscopy is required to confirm the diagnosis of hematuria. GH also must be distinguished from vaginal bleeding in women, which usually can be achieved by obtaining a careful menstrual history, collecting the specimen when the patient is not having menstrual or gynecologic bleeding, or, if necessary, obtaining a catheterized specimen. GH may also be detected by the presence of blood spotting on the undergarments of incontinent patients. After ruling out vaginal bleeding and mimics of hematuria, a urologic source must be suspected.

Differential Diagnosis

Hematuria should be differentiated from other disease which mimic hematuria especially hemoglobinuria and myoglobinuria which are dipstick positive but negative for microscopy.

Hematuria differential diagnosis

Differentiating the diseases that can cause hematuria:

			Symptoms						Physical examination			Lab Findings	Imaging			Histopathology
Diseases			Clinical manifestations									Para-clinical findings						Gold standard	Additional findings
			Symptoms						Physical examination			Para-clinical findings
			Low back pain	Fever	Nausea/Vomiting	Urinary symptoms			Hypertension	Pitting edema	Other		Ultrasonography	CT scan	Other	Histopathology
			Low back pain	Fever	Nausea/Vomiting	Dysuria	Frequency	Oliguria	Hypertension	Pitting edema	Other		Ultrasonography	CT scan	Other	Light microscopy	Immunoflourescence pattern
Hematuria	Glomerular diseases	IgA nephropathy (Berger nephropathy)		+	-	-	-	+	+	+	-	-
		Hereditary nephritis (Alport syndrome)	-	-	-	-	-	-	+	-	Cataract Hearing loss	Pyuria Red cell casts Cylindrical casts	-	-	Renal Biopsy Irregularly thin and attenuated GBM Splitting of GBM Scarring
		Poststreptococcal glomerulonephritis
		Mesangioproliferative glomerulonephritis
		Focal segmental glomerular sclerosis
		Rapidly progressive glomerulonephritis
		Lupus nephritis
		Thin basement membrane disease
		Fabry disease
	Tubulointerstitial diseases	Renal papillary necrosis
		Acute interstitial nephritis	+	+	+
		Analgesic
		Nephrolithiasis
		Reflux nephropathy (hydronephrosis)
	Malignancy	Renal cell carcinoma (RCC)
		Nephroblastoma
		Transitional cell carcinoma (TCC)
		Prostate cancer
	Familial diseases	Polycystic kidney disease	+	-	-	-	-	-	+	+	Palpable mass in the flank Palpable abdominal mass in the lumbar quadrant Palpable nodular hepatomegaly	Hypocitraturia in 65% on patients Hyperuricemia in 20% of patients Hyperoxaluria in 20% of patients Low urine pH Hematuria (microscopic or macroscopic) Proteinuria usually less than 1 g/day	Unilateral or bilateral cysts	Hyperdense appearance, Septations Calcifications	Genetic testing demonstrates: Frame insertions/deletions Non-canonical splice site alterations Combined missense changes	Interstitial fibrosis Tubular atrophy Thickening and lamellation of tubular basement membranes Microcysts	Negative immunofluorescence for complement and immunoglobulin	Ultrasound
	Vascular diseases	Renal vein thrombosis	+	+	+	-	-	-	-	-	Asymptomatic Abdominal pain Acute in onset	Elevation in serum lactate dehydrogenase Cholesterol levels for hypercholesterolemia Albumin levels for hypoalbuminemia Serum complement levels	Diagnostic screening		Renal venography: Gold standard
		Renal vein thrombosis	+	+	+	-	-	-	-	-	Asymptomatic Abdominal pain Acute in onset		Diagnostic screening		Renal venography: Gold standard
		Malignant hypertension
		Polyarteritis nodosa
		Wegner's granulomatosis polyangiitis
		Henoch-Schönlein purpura
	Lower urinary tract diseases	Benign prostatic hyperplasia
		Urolithiasis
		Interstitial cystitis
		Radiogenic cystitis
	Systemic diseases	Coagulopathy (hemophilia)
		Sickle cell anemia
		Abdominal aortic aneurysm
		Lymphomas
		Multiple myeloma
	Infectious diseases	Pyelonephritis	+	+	+	+	+	+	-	-	Delirium Headache	Positive leukocyte esterase test and nitrite test. Blood/urine cultures	Enlarged kidneys	Round swollen kidneys Hypodense appearance Abscesses may not be present	Contrast nephrograms Focal areas of striated or wedge-shaped hypoperfusion	Neutrophils Interstitial fibrosis Renal casts	-
		Cystitis	-	-	-	+	+	+	-	-	Dyspareunia Supra pubic tenderness	Pyuria: > 5-10 WBC/hpf or 27 WBC/microliter Positive leukocyte esterase test and nitrite test. Positive urine/blood cultures	Presence of a gas in the bladder wall. Also help to detect the presence of a tumor or a stone.		MRI Fibrosed bladder with a thick wall Hydronephrosis Calcification
		Prostatitis
		Urethritis
		Epididymitis
		Cytomegalovirus
		Infectious mononucleosis
		Condylomata acuminata
	Urogenital trauma	Inserted bladder or ureteral catheters
	Drugs	Anticoagulants
Dark urine	Hemoglobinuria	Autoimmune hemolytic anemia
		Microangiopathic hemolytic anemia
		Thrombotic thrombocytopenic purpura
		Paroxysmal nocturnal hemoglobinuria
		Paroxysmal cold hemoglobinuria
		Falciparum malaria
		Prosthetic heart valve
	Myoglobinuria	Crush injury
		Vigorous muscle exercise
		Hyperthermia (Heat stroke)
		Electric shock
		Prolonged seizure
		Polymyositis
		Trichinosis
		Haff disease
		Animal venom bite

References

Template:WH Template:WS

Hematuria differential diagnosis: Difference between revisions

Revision as of 18:23, 20 July 2018

Overview

Differential Diagnosis

Hematuria differential diagnosis

Differentiating the diseases that can cause hematuria:

References

Navigation menu

@@ Line 14: / Line 14: @@
 |- style="background: #4479BA; color: #FFFFFF; text-align: center;"
 ! colspan="3" rowspan="5" |Diseases
-| rowspan="5" |Type of hematuria
 | colspan="9" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
 ! colspan="8" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
@@ Line 47: / Line 46: @@
 | rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[IgA nephropathy|IgA nephropathy (Berger nephropathy)]]
-|Microscopic
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" | +
@@ Line 67: / Line 65: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alport syndrome|Hereditary nephritis (Alport syndrome)]]
-|Microscopic
 | style="background: #F5F5F5; padding: 5px;" | -
 | style="background: #F5F5F5; padding: 5px;" | -
@@ Line 96: / Line 93: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Poststreptococcal glomerulonephritis]]
-|Microscopic
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 118: / Line 114: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[MPGN|Mesangioproliferative glomerulonephritis]]
-|Microscopic
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 140: / Line 135: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]]
-|Microscopic
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 162: / Line 156: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]]
-|Microscopic
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 184: / Line 177: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lupus nephritis]]
-|Microscopic
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 206: / Line 198: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Thin basement membrane disease]]
-|Microscopic
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 228: / Line 219: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Fabry's disease|Fabry disease]]
-|Microscopic
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 251: / Line 241: @@
 | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tubulointerstitial diseases of the kidney|Tubulointerstitial diseases]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal papillary necrosis]]
-|Gross
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 273: / Line 262: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial nephritis|Acute interstitial nephritis]]
-|
 | style="background: #F5F5F5; padding: 5px;" | +
 | style="background: #F5F5F5; padding: 5px;" | +
@@ Line 295: / Line 283: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Analgesic]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 317: / Line 304: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephrolithiasis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 339: / Line 325: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Reflux nephropathy|Reflux nephropathy (hydronephrosis)]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 362: / Line 347: @@
 | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malignancy]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal cell carcinoma|Renal cell carcinoma (RCC)]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 384: / Line 368: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephroblastoma]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 406: / Line 389: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Transitional cell carcinoma|Transitional cell carcinoma (TCC)]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 428: / Line 410: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostate cancer]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 451: / Line 432: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Familial|Familial diseases]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polycystic kidney disease]]
-|Micro/Gross
 | style="background: #F5F5F5; padding: 5px;" | +
 | style="background: #F5F5F5; padding: 5px;" | -
@@ Line 494: / Line 474: @@
 | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vascular anomaly|Vascular diseases]]
 | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal vein thrombosis]]
-| rowspan="2" |Micro/Gross
 | rowspan="2" style="background: #F5F5F5; padding: 5px;" | +
 | rowspan="2" style="background: #F5F5F5; padding: 5px;" | +
@@ Line 527: / Line 506: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malignant hypertension]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 549: / Line 527: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polyarteritis nodosa]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 571: / Line 548: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Granulomatosis with polyangiitis|Wegner's granulomatosis polyangiitis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 593: / Line 569: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Henoch-Schönlein purpura]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 616: / Line 591: @@
 | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urinary system|Lower urinary tract diseases]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Benign prostatic hyperplasia]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 638: / Line 612: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urolithiasis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 660: / Line 633: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial cystitis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 682: / Line 654: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Radiogenic|Radiogenic cystitis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 705: / Line 676: @@
 | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic diseases]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemophilia|Coagulopathy (hemophilia)]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 727: / Line 697: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sickle cell anemia]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 749: / Line 718: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Abdominal aortic aneurysm]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 771: / Line 739: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomas]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 793: / Line 760: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple myeloma]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 816: / Line 782: @@
 | rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious disease|Infectious diseases]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyelonephritis]]
-|Gross
 | style="background: #F5F5F5; padding: 5px;" | +
 | style="background: #F5F5F5; padding: 5px;" | +
@@ Line 849: / Line 814: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cystitis]]
-|
+| style="background: #F5F5F5; padding: 5px;" | -
-| style="background: #F5F5F5; padding: 5px;" |-
+| style="background: #F5F5F5; padding: 5px;" | -
-| style="background: #F5F5F5; padding: 5px;" |-
+| style="background: #F5F5F5; padding: 5px;" | -
-| style="background: #F5F5F5; padding: 5px;" |-
+| style="background: #F5F5F5; padding: 5px;" | +
-| style="background: #F5F5F5; padding: 5px;" |+
+| style="background: #F5F5F5; padding: 5px;" | +
-| style="background: #F5F5F5; padding: 5px;" |+
+| style="background: #F5F5F5; padding: 5px;" | +
-| style="background: #F5F5F5; padding: 5px;" |+
+| style="background: #F5F5F5; padding: 5px;" | -
-| style="background: #F5F5F5; padding: 5px;" |-
+| style="background: #F5F5F5; padding: 5px;" | -
-| style="background: #F5F5F5; padding: 5px;" |-
 | style="background: #F5F5F5; padding: 5px;" |
 * [[Dyspareunia]]
@@ Line 880: / Line 844: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostatitis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 902: / Line 865: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urethritis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 924: / Line 886: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Epididymitis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 946: / Line 907: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cytomegalovirus]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 968: / Line 928: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious mononucleosis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 990: / Line 949: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Condylomata acuminata]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,013: / Line 971: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,036: / Line 993: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drugs]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Anticoagulants]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,057: / Line 1,013: @@
 | style="background: #F5F5F5; padding: 5px;" |
 |-
-| rowspan="18" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Dark urine]]
+| rowspan="16" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Dark urine]]
 | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemoglobinuria]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Autoimmune hemolytic anemia]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,082: / Line 1,037: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Microangiopathic hemolytic anemia]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,104: / Line 1,058: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Thrombotic thrombocytopenic purpura]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,126: / Line 1,079: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Paroxysmal nocturnal hemoglobinuria]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,148: / Line 1,100: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Paroxysmal cold hemoglobinuria]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,170: / Line 1,121: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malaria|Falciparum malaria]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,192: / Line 1,142: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prosthetic heart valve]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,215: / Line 1,164: @@
 | rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Myoglobinuria]]
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Crush injury]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,237: / Line 1,185: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Physical exercise|Vigorous muscle exercise]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,259: / Line 1,206: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hyperthermia|Hyperthermia (Heat stroke)]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,281: / Line 1,227: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Electric shock]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,303: / Line 1,248: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Prolonged [[seizure]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,325: / Line 1,269: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polymyositis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,347: / Line 1,290: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Trichinosis]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,369: / Line 1,311: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Haff disease]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 1,391: / Line 1,332: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bite injury|Animal venom bite]]
-|
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-|-
-| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Chemicals]]
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Phenazopyridine]]
-|
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-|-
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Beeturia|Beet (Beeturia)]]
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |

Hematuria differential diagnosis: Difference between revisions

Revision as of 18:23, 20 July 2018

Overview

Differential Diagnosis

Hematuria differential diagnosis

Differentiating the diseases that can cause hematuria:

References

Navigation menu

Search